Burks and Keet Publish Editorial on Oral Immunotherapy for High Threshold Peanut Allergy
Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, professor of pediatrics, Division of...
Allergy
EAACI Congress 2025 – Breaking Boundaries in Allergy,
ZURICH, March 18, 2025 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) proudly presents the EAACI...
Omalizumab treats multi-food allergy better than oral immunotherapy
News ReleaseMonday, March 3, 2025 High rate of oral immunotherapy side effects in NIH trial explains superiority of omalizumab.A clinical...
American Academy of Allergy, Asthma AND Immunology, Feb. 28-March 3
The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 3 in San...
UNC ‘Breakthrough’ Research on Food Allergy Drug Featured in National Geographic
Drug work one of “7 Medical Breakthroughs that Changed Medicine in 2024.” Edwin Kim, MD, chief of the Division of...
NICE approves house dust mite allergy therapy for those with severe symptoms
A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been...
